Index Every US public charity, on the record

Cancer Research & Treatment Fund Inc

New York, New York
EIN 13-6272085Grantmaking public charityLatest return year ending December 2025Its profile as a public charity

Applications

Applications

Schedule I of Form 990 lists the grants made, not how to apply, so this return does not say whether Cancer Research & Treatment Fund Inc accepts applications.

From its returns

What it gave

Cancer Research & Treatment Fund Inc paid $603,523 in grants in the year ending December 2025.

Grants paid
$603,523
Year ending December 2025
Grants listed
2
To organizations, on that return
Typical grant
$296,400
Half fall between $198,200 and $394,600
Year endingGrants paidGrants listed
December 2025$603,5232
December 2024$542,6501

From Schedule I of its Form 990 returns for the years ending December 2024 to December 2025.

Focus and places

What it funds, and where

From the 3 grants listed on its returns for the years ending December 2024 to December 2025. A grant counts toward a focus only when it is linked to the charity that received it: 0 of 3 are.

Focus, by share of linked grant dollars

None of its grants could be linked to a charity with certainty, so no focus is shown.

Where it gave, by number of grants

  • New York3

From Schedule I of its Form 990 returns for the years ending December 2024 to December 2025.

Grants

Recent grants to organizations

The largest grants on its latest returns, as filed. A name links to the charity’s profile when the match is certain.

RecipientYear endingAmountPurpose
WEILL CORNELL MEDICAL COLLEGENew York, New YorkDecember 2025$492,800RESEARCH- MYELOPROLIFERATIVE NEOPLA
WEILL CORNELL MEDICAL COLLEGENew York, New YorkDecember 2025$100,000PANCREATIC CANCER RESEARCH
WEILL CORNELL MEDICAL COLLEGENew York, New YorkDecember 2024$521,050RESEARCH- MYELOPROLIFERATIVE NEOPLA

Showing 3 of the 3 grants listed on its returns for the years ending December 2024 to December 2025. From Schedule I of its Form 990 returns for the years ending December 2024 to December 2025.